The Role of Hexamidine Diisethionate (Zamidineae) 1mg/ml Eye Drops in Preventing Infection During Eye Surgery

What this Trial Is About

Researchers are studying patients with recurrent conjunctivitis who are scheduled for various eye surgeries, such as intravitreal injections, glaucoma surgery, cataract surgery, vitrectomy, combined cataract and vitrectomy, or corneal transplantation. The trial aims to evaluate whether using Zamidineae eye drops can reduce the bacterial flora on the eye surface before surgery. This observational study will collect data from medical records while following routine clinical practices for these eye conditions. Participants will have conjunctival swabs taken at several time points: four days before surgery to check for unusual bacteria, on the day of surgery before entering the recovery room, and after three minutes of applying 5% iodopovidone to the eye. Data on bacterial species and load will be analyzed before and after surgery. Follow-up information will be gathered from medical records 24 and 30 days after surgery to assess outcomes. During the study, researchers will collect data using pseudonyms to protect patient identity. They will monitor bacterial species present on the eye surface before and after antiseptic treatment and surgery. The primary measurement is the bacterial species found at these different times. The total study participation spans from before surgery through about one month of follow-up after the procedure, with no additional interventions beyond standard care and swab collections.

THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMIC